A ten-year single-centre study from Istanbul documents the clinical presentation, staging, treatment and long-term follow-up ...

Mycosis fungoides is a rare type of blood cancer that starts in the skin. It often involves a rash that does not go away, can appear anywhere on the skin, and may be itchy. Early treatment can be ...

Therapeutic options are being sequenced to improve outcomes in patients with the relatively rare cutaneous T-cell lymphomas mycosis fungoides and Sézary syndrome, in a global, real-world study.

Cutaneous T cell lymphomas (CTCL) represent a heterogeneous group of T-cell malignancies that manifest primarily in the skin. By far the most common variant of CTCL is mycosis fungoides and its ...

The mycosis fungoides market is anticipated to progress steadily, influenced by the relatively small pipeline of emerging therapies. Leading candidates such as Soligenix's HYBRYTE and Innate Pharma's ...

In a recent clinical letter published by the Brazilian Society of Dermatology, researchers highlight the potential role of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in ...

This page lists all known medications that could potentially lead to 'Mycosis fungoides' as a side effect. It's important to note that mild side effects are quite common with medications. The ...

The field of measurement in Mycosis Fungoides/Sézary syndrome type cutaneous T-cell lymphoma lacked a specific quality-of-life measure to describe patient experience or guide treatment decisions.

Hypopigmented mycosis fungoides is an uncommon clinical variant of cutaneous T-cell lymphoma. We hypothesized that hypomelanosis in hypopigmented mycosis fungoides may have a similar mechanism as in ...

Mycosis fungoides is a type of cutaneous T-cell lymphoma, a cancer caused by abnormal proliferation of a type of white blood cells called T lymphocytes or T-cells and their infiltration into the skin.

Cutaneous T-cell lymphoma represents a complex array of disorders with various manifestations, clinical courses, and therapeutic considerations. Mycosis fungoides — in which the skin is variably ...